As part of their strategic investment partnership, Domain Associates and RusnanoMedInvest (a subsidiary of Rusnano) have made their first joint investment of nearly $40 million into San Diego, California-based CoDa Therapeutics. The funds will be used by CoDa to "pursue late-stage clinical trials".
In March, Domain, a large US healthcare-focused venture capital firm, and Rusnano, the Russian state-owned investor in high-tech industries, entered...